Get started
Author

Julia Whitman

Assessment and Comparison of 18 F-Fluorocholine PET and 99m Tc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
2021 · Julia Whitman, Isabel E. Allen, et al. · Journal of Nuclear Medicine · 54
PDF
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap
2023 · Sarah E. Umetsu, Sanjay Kakar, et al. · Modern Pathology · 51
PDF
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
2021 · David L. Chan, Emily K. Bergsland, et al. · The Oncologist · 42
PDF
Health literacy and all‐cause mortality among cancer patients
2025 · Bashir Al Hussein Al Awamlh, Kelvin A. Moses, et al. · Cancer · 25
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.
2021 · Andrea Grace Bocobo, Renee Wang, et al. · Journal of Clinical Oncology · 17
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms
2021 · Katherine S. Chen, Courtney Lawhn-Heath, et al. · PLoS ONE · 12
PDF
Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time
2023 · Stephanie J. Wang, Julia Whitman, et al. · Journal of Neuroendocrinology · 11
Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review
2023 · Bryan Khuong Le, Patrick McGarrah, et al. · Clinical Genitourinary Cancer · 10
Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.
2019 · David Chan, Emily K. Bergsland, et al. · Journal of Clinical Oncology · 10
Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study
2021 · Yosuke Kasai, Toshihiko Masui, et al. · Pancreatology · 7
PDF
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
2022 · Andrea Grace Bocobo, Renee Wang, et al. · Journal of Clinical Oncology · 6
Outcomes after high-dose radiation in management of neuroendocrine neoplasms.
2020 · Katherine Chen, Julia Whitman, et al. · Journal of Clinical Oncology · 5
Complete Response and Immune-Mediated Adverse Effects With Checkpoint Blockade: Treatment of Mismatch Repair–Deficient Colorectal Neuroendocrine Carcinoma
2019 · Julia Whitman, Adel Kardosh, et al. · JCO Precision Oncology · 5
Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities— A Rigorous Structural Equation Modeling
2025 · Alan Paciorek, Claire Mulvey, et al. · Journal of the National Comprehensive Cancer Network · 4
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer
2026 · Julia Whitman, Chloe E. Attreya, et al. · SSRN Electronic Journal · 1
Emerging value of multigene panels for germline testing in patients with neuroendocrine tumors.
2018 · Julia Whitman, Brandon Shih, et al. · Journal of Clinical Oncology · 1
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer
2026 · Andrea Bocobo, Julia Whitman, et al. · Clinical Colorectal Cancer
56 Impact of ACTIV-6 treatment on PROMIS-29 at 7, 14, 28, and 90 days
2024 · Julia Whitman, Mark Sulkowski, et al. · Journal of Clinical and Translational Science
PDF
Author response for "Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time"
2023 · Stephanie J. Wang, Julia Whitman, et al.
Author response for "Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time"
2023 · Stephanie J. Wang, Julia Whitman, et al.
Works count: 20
Citation count: 261
H-index: 9
I10-index: 9
Year
Topic
Type